DANIEL M. JUNIUS - 05 Dec 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role: Director
Signature: /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Issuer symbol: IDXX
Transactions as of: 05 Dec 2022
Net transactions value: -$806,063
Form type: 4
Filing time: 07 Dec 2022, 15:30:49 UTC
Previous filing: 18 Nov 2022
Next filing: 01 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IDXX	Common Stock	Options Exercise	$488,213	+3,046	+103%	$160.28	6,014	05 Dec 2022	Direct
transaction	IDXX	Common Stock	Sale	$1,294,276	-3,046	-51%	$424.91	2,968	05 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IDXX	Non-Qualified Stock Option (right-to-buy)	Options Exercise		-3,046	-100%		0	05 Dec 2022	Common Stock	3,046	$160.28	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of option to buy 3,046 shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of shareholders, whichever event was earlier.
F2	Not applicable.